Tokyo Tape
Sign in
← Ubicom Holdings

Quarterly report · Q2

3937.TEDINET S100S6A8
Period2023-04-01 → 2023-09-30
Filed2023-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥2.9bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥5.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥2.6bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥541m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥502m2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥467m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥1.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥495m2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥467m2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥495m2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥301m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥574m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥337m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥301m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥337m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥6.4bnat 2023-09-30Cons.Assets
Total assets¥5.8bnat 2023-03-31Cons.Assets
Total assets¥5.9bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥2.1bnat 2023-09-30Cons.Liabilities
Total liabilities¥1.7bnat 2023-03-31Cons.Liabilities
Net assets / equity¥4.4bnat 2023-09-30Cons.Net assets
Net assets / equity¥4.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥4.1bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥3.9bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥3.8bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.6bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.3bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥504m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥821m2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥498m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥221m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥111m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥33m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥169m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥447m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥235m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥25.572023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥16.62023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.682022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.582022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥12.242022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥25.12023-04-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥47.572022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥27.882022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio67.8%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio70.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio69.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 39
SegmentItemPeriodValue
Otherother segmentsrevenue2023-04-01 → 2023-09-30¥600,000
Otherother segmentsrevenue external2023-04-01 → 2023-09-30¥600,000
Otherother segmentssegment profit2023-04-01 → 2023-09-30¥300,000
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥17m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥17m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥170m
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.1bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥17m
jpcrp040300-q2r_E32408-000Globalreportable segmentsegment profit2023-04-01 → 2023-09-30¥233m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue2023-04-01 → 2023-09-30¥798m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue external2023-04-01 → 2023-09-30¥798m
jpcrp040300-q2r_E32408-000Medicalreportable segmentsegment profit2023-04-01 → 2023-09-30¥477m
—segment totalrevenue2023-04-01 → 2023-09-30¥2.9bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥2.9bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥17m
—segment totalsegment profit2023-04-01 → 2023-09-30¥711m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥17m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥711m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥22m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥22m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥159m
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue2022-04-01 → 2022-09-30¥1.9bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.8bn
jpcrp040300-q2r_E32408-000Globalreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥22m
jpcrp040300-q2r_E32408-000Globalreportable segmentsegment profit2022-04-01 → 2022-09-30¥216m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue2022-04-01 → 2022-09-30¥756m
jpcrp040300-q2r_E32408-000Medicalreportable segmentrevenue external2022-04-01 → 2022-09-30¥756m
jpcrp040300-q2r_E32408-000Medicalreportable segmentsegment profit2022-04-01 → 2022-09-30¥444m
—segment totalrevenue2022-04-01 → 2022-09-30¥2.6bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥2.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥22m
—segment totalsegment profit2022-04-01 → 2022-09-30¥660m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥22m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥660m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 487
ItemContextValueUnit
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfPrior1YTDDuration12250000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration9752000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-94771000JPY
Purchase of treasury stock fin cfCurrentYTDDuration－JPY
Repayments of lease obligations fin cfPrior1YTDDuration-45814000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-49121000JPY
Cash dividends paid fin cfPrior1YTDDuration-106473000JPY
Cash dividends paid fin cfCurrentYTDDuration-129167000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-234818000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-168537000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration57862000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration78966000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration287608000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration193447000JPY
Cash and cash equivalentsPrior2YearInstant3342526000JPY
Cash and cash equivalentsPrior1YearInstant3636780000JPY
Cash and cash equivalentsPrior1QuarterInstant3630135000JPY
Cash and cash equivalentsCurrentQuarterInstant3830227000JPY
Salaries and allowances sgaPrior1YTDDuration158059000JPY
Salaries and allowances sgaCurrentYTDDuration156462000JPY
Provision for bonuses sgaPrior1YTDDuration23728000JPY
Provision for bonuses sgaCurrentYTDDuration18998000JPY
Retirement benefit expenses sgaPrior1YTDDuration6149000JPY
Retirement benefit expenses sgaCurrentYTDDuration7020000JPY
Provision of allowance for doubtful accounts sgaPrior1YTDDuration74000JPY
Provision of allowance for doubtful accounts sgaCurrentYTDDuration-5116000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember1846318000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember756344000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember2602662000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2602662000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration2602662000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember22182000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember22182000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember22182000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-22182000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember1868500000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember756344000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember2624844000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember2624844000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-22182000JPY
Net salesPrior1YTDDuration2602662000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E32408-000GlobalReportableSegmentMember216134000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E32408-000MedicalReportableSegmentMember443980000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember660115000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember660115000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-158537000JPY
Operating incomePrior1YTDDuration501577000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass